These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Structural basis for the activation of PPARgamma by oxidized fatty acids. Itoh T; Fairall L; Amin K; Inaba Y; Szanto A; Balint BL; Nagy L; Yamamoto K; Schwabe JW Nat Struct Mol Biol; 2008 Sep; 15(9):924-31. PubMed ID: 19172745 [TBL] [Abstract][Full Text] [Related]
28. Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site. Jang JY; Koh M; Bae H; An DR; Im HN; Kim HS; Yoon JY; Yoon HJ; Han BW; Park SB; Suh SW Biochim Biophys Acta Proteins Proteom; 2017 Jun; 1865(6):674-681. PubMed ID: 28342850 [TBL] [Abstract][Full Text] [Related]
34. Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications. Batista MR; Martínez L J Phys Chem B; 2015 Dec; 119(50):15418-29. PubMed ID: 26598113 [TBL] [Abstract][Full Text] [Related]
35. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators. Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031 [TBL] [Abstract][Full Text] [Related]
36. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties. Li Y; Wang Z; Furukawa N; Escaron P; Weiszmann J; Lee G; Lindstrom M; Liu J; Liu X; Xu H; Plotnikova O; Prasad V; Walker N; Learned RM; Chen JL J Biol Chem; 2008 Apr; 283(14):9168-76. PubMed ID: 18263587 [TBL] [Abstract][Full Text] [Related]
37. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure. Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122 [TBL] [Abstract][Full Text] [Related]
38. An alternate binding site for PPARγ ligands. Hughes TS; Giri PK; de Vera IM; Marciano DP; Kuruvilla DS; Shin Y; Blayo AL; Kamenecka TM; Burris TP; Griffin PR; Kojetin DJ Nat Commun; 2014 Apr; 5():3571. PubMed ID: 24705063 [TBL] [Abstract][Full Text] [Related]
39. The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites. Waku T; Shiraki T; Oyama T; Maebara K; Nakamori R; Morikawa K EMBO J; 2010 Oct; 29(19):3395-407. PubMed ID: 20717101 [TBL] [Abstract][Full Text] [Related]
40. CHARMM Force Field Parameterization of Peroxisome Proliferator-Activated Receptor γ Ligands. Mottin M; Souza PC; Ricci CG; Skaf MS Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]